A digital tool to track speech decline in ALS patients
A digital tool for monitoring speech decline in ALS
This study is testing a new online tool that helps track changes in speech for people with ALS, making it easier to spot problems early and improve communication for those affected by the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Modality.ai , INC NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10875504 on NIH RePORTER |
What this research studies
This research focuses on developing a digital tool called the Modality Digital Speech Monitoring Tool (M-DSMT) to monitor speech decline in patients with Amyotrophic Lateral Sclerosis (ALS). The tool aims to provide an automated, online, and objective assessment of speech changes, which can be crucial for early diagnosis and monitoring of the disease. By utilizing artificial intelligence, the M-DSMT will be accessible and scalable, allowing for real-time monitoring of speech performance. This innovative approach seeks to improve the quality of life for ALS patients by addressing the significant communication challenges they face.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with Amyotrophic Lateral Sclerosis.
Not a fit: Patients with other neurological conditions that do not involve speech decline may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnosis and monitoring of speech decline in ALS patients, ultimately improving their quality of life.
How similar studies have performed: While there is limited research on digital speech monitoring tools specifically for ALS, the use of technology in monitoring neurological conditions has shown promise in other areas.
Where this research is happening
San Francisco, United States
- Modality.ai , INC — San Francisco, United States (Active)
Researchers
- Principal investigator: Green, Jordan R — Modality.ai , INC
- Study coordinator: Green, Jordan R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.